"Myriad is committed to advancing personalized medicine and providing oncologists with high-quality genetic information to enhance care for their patients," said Johnathan Lancaster, M.D., Ph.D., chief medical officer, Myriad Genetics.
"At this year’s ASCO, we are excited to present multiple studies that highlight the clinical performance of several of Myriad’s genetic tests.”A list of presentation at ASCO 2019 are below. Please visit Myriad Genetics at booth #5087 to learn more about our leading portfolio of personalized medicine products. Follow Myriad on Twitter via @myriadgenetics and keep up to date with ASCO meeting news and updates by using the hashtag #ASCO19.
Complete ASCO 2019 Conference Highlights Coming Soon!